1558 related articles for article (PubMed ID: 27655588)
1. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis.
Bonde JP; Flachs EM; Rimborg S; Glazer CH; Giwercman A; Ramlau-Hansen CH; Hougaard KS; Høyer BB; Hærvig KK; Petersen SB; Rylander L; Specht IO; Toft G; Bräuner EV
Hum Reprod Update; 2016 Dec; 23(1):104-125. PubMed ID: 27655588
[TBL] [Abstract][Full Text] [Related]
2. Prenatal and postnatal exposures to endocrine disrupting chemicals and timing of pubertal onset in girls and boys: a systematic review and meta-analysis.
Uldbjerg CS; Koch T; Lim YH; Gregersen LS; Olesen CS; Andersson AM; Frederiksen H; Coull BA; Hauser R; Juul A; Bräuner EV
Hum Reprod Update; 2022 Aug; 28(5):687-716. PubMed ID: 35466359
[TBL] [Abstract][Full Text] [Related]
3. Temporal decline of sperm concentration: role of endocrine disruptors.
Cannarella R; Gül M; Rambhatla A; Agarwal A
Endocrine; 2023 Jan; 79(1):1-16. PubMed ID: 36194343
[TBL] [Abstract][Full Text] [Related]
4. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517
[TBL] [Abstract][Full Text] [Related]
5. Exposure to non-persistent chemicals in consumer products and fecundability: a systematic review.
Hipwell AE; Kahn LG; Factor-Litvak P; Porucznik CA; Siegel EL; Fichorova RN; Hamman RF; Klein-Fedyshin M; Harley KG;
Hum Reprod Update; 2019 Jan; 25(1):51-71. PubMed ID: 30307509
[TBL] [Abstract][Full Text] [Related]
6. Per- and polyfluoroalkyl substances and male reproductive health: a systematic review of the epidemiological evidence.
Petersen KU; Larsen JR; Deen L; Flachs EM; Hærvig KK; Hull SD; Bonde JPE; Tøttenborg SS
J Toxicol Environ Health B Crit Rev; 2020 Aug; 23(6):276-291. PubMed ID: 32741292
[TBL] [Abstract][Full Text] [Related]
7. Regional differences and temporal trends in male reproductive health disorders: semen quality may be a sensitive marker of environmental exposures.
Nordkap L; Joensen UN; Blomberg Jensen M; Jørgensen N
Mol Cell Endocrinol; 2012 May; 355(2):221-30. PubMed ID: 22138051
[TBL] [Abstract][Full Text] [Related]
8. Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men.
Rodprasert W; Toppari J; Virtanen HE
Front Endocrinol (Lausanne); 2021; 12():706532. PubMed ID: 34690925
[TBL] [Abstract][Full Text] [Related]
9. Environmental factors in genitourinary development.
Yiee JH; Baskin LS
J Urol; 2010 Jul; 184(1):34-41. PubMed ID: 20478588
[TBL] [Abstract][Full Text] [Related]
10. Endocrine disruptors and the male reproductive system.
Stukenborg JB; Mitchell RT; Söder O
Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101567. PubMed ID: 34426080
[TBL] [Abstract][Full Text] [Related]
11. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection.
Toppari J; Virtanen HE; Main KM; Skakkebaek NE
Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):910-9. PubMed ID: 20865786
[TBL] [Abstract][Full Text] [Related]
12. Environmental and individual exposure and the risk of congenital anomalies: a review of recent epidemiological evidence.
Baldacci S; Gorini F; Santoro M; Pierini A; Minichilli F; Bianchi F
Epidemiol Prev; 2018; 42(3-4 Suppl 1):1-34. PubMed ID: 30066535
[TBL] [Abstract][Full Text] [Related]
13. Contribution of prenatal endocrine-disrupting chemical exposure to genital anomalies in males: The pooled results from current evidence.
Wu Y; Wang J; Wei Y; Chen J; Kang L; Long C; Wu S; Shen L; Wei G
Chemosphere; 2022 Jan; 286(Pt 3):131844. PubMed ID: 34392196
[TBL] [Abstract][Full Text] [Related]
14. Parental occupational exposure to endocrine disrupting chemicals and male genital malformations: a study in the Danish National Birth Cohort study.
Morales-Suárez-Varela MM; Toft GV; Jensen MS; Ramlau-Hansen C; Kaerlev L; Thulstrup AM; Llopis-González A; Olsen J; Bonde JP
Environ Health; 2011 Jan; 10(1):3. PubMed ID: 21235764
[TBL] [Abstract][Full Text] [Related]
15. Endocrine disruptors and testicular function.
Lymperi S; Giwercman A
Metabolism; 2018 Sep; 86():79-90. PubMed ID: 29605435
[TBL] [Abstract][Full Text] [Related]
16. Effect of environmental and pharmaceutical exposures on fetal testis development and function: a systematic review of human experimental data.
Kilcoyne KR; Mitchell RT
Hum Reprod Update; 2019 Jul; 25(4):397-421. PubMed ID: 30869130
[TBL] [Abstract][Full Text] [Related]
17. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies.
Storgaard L; Bonde JP; Olsen J
Reprod Toxicol; 2006 Jan; 21(1):4-15. PubMed ID: 16005180
[TBL] [Abstract][Full Text] [Related]
18. Endocrine Disrupting Chemicals and Risk of Testicular Cancer: A Systematic Review and Meta-analysis.
Bräuner EV; Lim YH; Koch T; Uldbjerg CS; Gregersen LS; Pedersen MK; Frederiksen H; Petersen JH; Coull BA; Andersson AM; Hickey M; Skakkebæk NE; Hauser R; Juul A
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4834-e4860. PubMed ID: 34270734
[TBL] [Abstract][Full Text] [Related]
19. Testicular dysgenesis syndrome: possible role of endocrine disrupters.
Bay K; Asklund C; Skakkebaek NE; Andersson AM
Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):77-90. PubMed ID: 16522521
[TBL] [Abstract][Full Text] [Related]
20. Endocrine disrupting chemicals and their effects on the reproductive health in men.
Thacharodi A; Hassan S; Acharya G; Vithlani A; Hoang Le Q; Pugazhendhi A
Environ Res; 2023 Nov; 236(Pt 2):116825. PubMed ID: 37544467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
